95 filings
Page 2 of 5
8-K
xz164
13 Jan 22
Unregistered Sales of Equity Securities
4:00pm
8-K
3jrntb4229v5
12 Nov 21
Eledon Pharmaceuticals Reports Third Quarter 2021 Operating and Financial Results
6:32am
8-K
o5a7f
12 Aug 21
Eledon Pharmaceuticals Reports Second Quarter 2021 Operating and Financial Results
4:00pm
8-K
h44pgcku7wl36753e1r
2 Aug 21
Departure of Directors or Certain Officers
9:00am
8-K
x0bk6jlbi3mcuf
2 Jul 21
Departure of Directors or Certain Officers
8:30am
8-K
hmay98huowdr81
16 Jun 21
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
32o k2m4k
13 May 21
Eledon Pharmaceuticals Reports First Quarter 2021 Operating and Financial Results
4:22pm
8-K
0juzdvaws wghov46uz
27 Apr 21
Eledon Pharmaceuticals Announces Update on Development Strategy for AT-1501 in Renal Transplantation
12:00am
8-K
i83rwqn r4bremdxy
15 Mar 21
Departure of Directors or Certain Officers
2:00pm
8-K
wrz03ystk
7 Jan 21
Unregistered Sales of Equity Securities
8:00am
8-K
4s2hedzvn8ckyverk7xc
5 Jan 21
Novus Therapeutics Announces Name Change to Eledon Pharmaceuticals; Provides Corporate Update and Outlook
4:10pm
8-K
ngk6lz3fy70 5stjm2
22 Dec 20
Submission of Matters to a Vote of Security Holders
8:16am
8-K
8k0h84 ow5
10 Dec 20
Amendments to Articles of Incorporation or Bylaws
5:00pm
8-K
4vsp1kps5yemf
20 Nov 20
Amendments to Articles of Incorporation or Bylaws
4:18pm
8-K/A
c7r6n0xs2o2pulm m0v
20 Nov 20
Financial Statements and Exhibits
8:32am
8-K
25e00xoe8h69 16ffiw
6 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:45pm
8-K
32qizekiupnknb3q
15 Sep 20
Novus Therapeutics Announces Acquisition of Anelixis Therapeutics
5:19pm
8-K
z738t 9wtsadlfd4cg
4 Sep 20
Departure of Directors or Certain Officers
4:25pm
8-K
jd1s jqrxd
17 Jun 20
Cost Associated with Exit or Disposal Activities
4:05pm
8-K
ytrq61
15 May 20
Novus Therapeutics Reports First Quarter 2020 Financial Results
6:32am